{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:10Z","timestamp":1760833150081,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.nmd.2004.02.014","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T05:50:57Z","timestamp":1083217857000},"page":"375-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitochondrial dysfunction and rod-like lesions associated with administration of \u03b22 adrenoceptor agonist formoterol"],"prefix":"10.1016","volume":"14","author":[{"given":"Matthew C","family":"Kiernan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bullpitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane H.L","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2004.02.014_BIB1","series-title":"Walton's Disorders of Voluntary Muscle","first-page":"989","article-title":"Drug-induced neuromuscular disorders","author":"Argov","year":"1994"},{"key":"10.1016\/j.nmd.2004.02.014_BIB2","series-title":"Structure and Molecular Basis of Skeletal Muscle Diseases","first-page":"246","article-title":"Toxic and iatrogenic disorders","author":"Argov","year":"2002"},{"key":"10.1016\/j.nmd.2004.02.014_BIB3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2004.02.014_BIB4","first-page":"105","article-title":"Nemaline myopathy: description of an adult onset case","volume":"34","author":"Ginanneschi","year":"2002","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.nmd.2004.02.014_BIB5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003495-199855020-00016","article-title":"Formoterol: An update of its pharmacological properties and therapeutic efficacy in the management of asthma","volume":"55","author":"Bartow","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.nmd.2004.02.014_BIB6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1081-1206(10)63356-X","article-title":"Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol","volume":"77","author":"Craig","year":"1996","journal-title":"Annals of Allergy, Asthma and Immunology"},{"key":"10.1016\/j.nmd.2004.02.014_BIB7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0091-6749(85)90650-5","article-title":"Beta agonists: adrenergic bronchodilators: pharmacology and toxicity","volume":"76","author":"Reed","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nmd.2004.02.014_BIB8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0300-9084(92)90125-X","article-title":"Effect of \u03b2-agonists on expression of calpain and calpastatin activity in skeletal muscle","volume":"74","author":"Bardsley","year":"1992","journal-title":"Biochimie"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896604000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:52:19Z","timestamp":1760773939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896604000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0960896604000677"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2004.02.014","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction and rod-like lesions associated with administration of \u03b22 adrenoceptor agonist formoterol","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2004.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}